The Life Improvement Trial (LIFT)

Headshots of Jonas Bergquist and David Systrom alongside the text “The LIFT.”

The Life Improvement Trial (LIFT) aims to investigate two drugs, separately and in combination, Pyridostigmine (commonly known as Mestinon) and Low-Dose Naltrexone (LDN), for efficacy and to research the difference between responders and non-responders.

Sleep Disturbance in ME/CFS

We intend to examine multiple sleep studies that have been conducted in the past two years and performed at the MGH Neurology Sleep Medicine Laboratory in well characterized patients with ME/CFS.

Heart Preload Failure

This study aims to evaluate different explanations of preload failure in ME/CFS patients.